Targeted cancer therapy and its ophthalmic side effects: a review

SH Bindiganavile, N Bhat, AG Lee… - Journal of …, 2021 - meridian.allenpress.com
Targeted cancer therapy agents are the latest development in cancer therapeutics. Although
the spectrum of their use continues to expand, ocular side effects are frequently encountered …

Neuro-ophthalmic complications of modern anti-cancer drugs

JA Oskam, HV Danesh-Meyer - Graefe's Archive for Clinical and …, 2024 - Springer
Purpose Targeted cancer therapies have been responsible for a dramatic shift in treatment
strategies for cancer, and the number of drugs, classes, and indications are continually …

Клинические проявления и механизмы развития поражения глаз при гемобластозах

НЮ Юсеф, ЕН Мисюрина, ДВ Анджелова… - …, 2023 - ophthalmojournal.com
Аннотация В статье рассмотрены различные офтальмологические проявления при
гемобластозах. Представлено подробное описание наиболее распространенных …

Cytostatic Agents

S Keshishyan, HL Nguyen, OD Afolabi, C Moore… - Side Effects of Drugs …, 2018 - Elsevier
Abstract The Side Effects of Drugs Annuals is a series of volumes in which the adverse
effects of drugs and adverse reactions to them are surveyed. The series supplements the …

Ocular toxicity with TKI therapy in CML

ME Couto, I Oliveira, S Estrela-Silva… - Authorea …, 2021 - essopenarchive.org
Tyrosine kinase inhibitors are the standard treatment for Chronic Myeloid Leukemia. They
have significantly improved the response rate and global survival in the long term for CML …

[PDF][PDF] Bilateral Optic Neuropathy in a Patient with Imatinib Usage

RD Gün, A Koçkar, B Altunrende… - Turkiye Klinikleri J …, 2020 - pdfs.semanticscholar.org
ABS TRACT A 59-year-old woman presented with a painless vision loss in her left eye for
five days. The nasal side of the right optic nerve head was mildly oedematous and …